Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 5,962.00 Million |
| USD 11,462.00 Million | |
| % | |
U.S. Women’s Health Diagnostics Market, By Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers and Others), Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing and Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centres, Clinics and Home Care Setting) – Industry Trends and Forecast to 2030.
Women's health is the branch of medicine that mainly focuses on the treatment and diagnosis of diseases and conditions that affect a woman's health. Women's health diagnostic method includes screening, testing, or diagnosing, and monitoring of several women-related disorders, such as breast cancer, ovarian cancer, cervical cancer, menopause, and pregnancy. Different types of test are available for the diagnosis women health-related diseases. The medical diagnostics devices, such as biopsy device, imaging & monitoring system, mammography system, and other detect cancer, remove blockages, and capture the images of internal organs help for screening & diagnosis of disease. The diagnostic test includes breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy, ovulation testing and ovarian cancer testing. The use of tests for screening and detection of various disorders is necessary to prevent complications and improve quality of life. Health tests are vital for improving health and preventing and treating serious diseases.
Data Bridge Market Research analyses that the women’s health diagnostics market which was USD 5,962.00 million in 2023, would rocket up to USD 11,462.00 million by 2030, and is expected to undergo a CAGR of 8.5% during the forecast period. This indicates that the market value. “Imaging and Monitoring Systems” dominates the diagnostic devices segment of the women’s health diagnostics market owing to the increase in incidence of chronic and lifestyle disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers and Others), Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing and Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centres, Clinics and Home Care Setting)
|
|
Countries Covered
|
U.S
|
|
Market Players Covered
|
bioMérieux SA, Carestream Health, MEDGYN PRODUCTS, INC., COOK, Cardinal Health, PerkinElmer Inc. GENERAL ELECTRIC, Quest Diagnostics Incorporated, Sysmex Corporation, Siemens, Hologic Inc., Abbott, BD, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., NeuroLogica Corp., Danaher, FUJIFILM Holdings Corporation, Hitachi, Ltd., Canon Inc., among others.
|
|
Market Opportunities
|
|
Market Definition
The U.S. women's health diagnostic market refers to the healthcare industry segment focused on developing, manufacturing, and distributing medical diagnostic tests and devices specifically designed for assessing and monitoring women's health conditions. These diagnostic tests and devices are used by healthcare professionals to detect, diagnose, and manage various diseases and conditions that primarily affect women, including reproductive health issues, gynaecological disorders, breast cancer, cervical cancer, menopause-related conditions, and other female-specific health concerns.
Drivers
There has been a significant rise in public awareness and recognition of women's health issues, leading to the increased demand for diagnostic tests and screenings. The government initiatives, advocacy campaigns, and educational efforts have played a crucial role in emphasizing the importance of early detection and prevention of women's health conditions. This in turn has carved the way for the growth of the market.
There is a growing emphasis on preventive healthcare, including regular screenings and early detection of diseases. Women's health diagnostics enable early identification of risk factors, allowing healthcare providers to implement preventive measures and personalized treatment plans. This focus on prevention contributes to the growth of the market.
Ongoing research and development efforts in the field of women's health diagnostics lead to the introduction of innovative technologies, tests, and devices. This drives market growth by expanding the range of diagnostic options available and improving their accuracy, reliability, and accessibility.
Opportunities
Rapid advancements in medical technologies, such as molecular diagnostics, next-generation sequencing, imaging modalities, and point-of-care testing, have revolutionized the field of women's health diagnostics. These innovations have led to more accurate, sensitive, and efficient diagnostic tools, enabling early detection, personalized treatment strategies, and improved patient outcomes. Thus, advancements in diagnostic technologies is expected to act as an opportunity for the growth of market.
Restraints/Challenges
The cost of diagnostic tests and devices can be a barrier to access for certain segments of the population. High costs may limit the adoption of advanced diagnostic technologies and screening programs, particularly among uninsured or underinsured individuals. Addressing affordability concerns is crucial to ensure equitable access to women's health diagnostics. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, heavy custom duty imposed on the medical devices, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This women’s health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
The women’s health diagnostics market is segmented on the basis of diagnostic devices, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnostic Devices
Application
End User
The women’s health diagnostics market is analyzed and market size insights and trends are provided by country, diagnostic devices, application, and end user as referenced above.
The countries covered in the women’s health diagnostics market report is U.S.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The women’s health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for women’s health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the women’s health diagnostics market. The data is available for historic period 2010-2020.
The women’s health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to women’s health diagnostics market.
Some of the major players operating in the women’s health diagnostics market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.